Statewide
Bureau of EMS, Trauma & Preparedness
Bureau of EMS, Trauma & Preparedness (MI) carries 36 drugs across 153 dose entries in its current published protocol, effective 2018-03-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses36
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg | PO | not captured | standing | page 87 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 87 |
| Mild to moderate pain | adult | 15 mg/kg | PO | not captured | standing | page 87 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 87 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | page 100 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 100 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 2.5 mg | not captured | not captured | standing | page 34 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | page 63 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | page 63 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 95 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 95 |
| Narrow-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 101 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324–325 mg | PO | not captured | standing | page 104 |
| ACS / chest pain | adult | 324–325 mg | PO | not captured | standing | page 104 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | page 99 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 99 |
| Nerve agent exposure | adult | 2–6 mg | IV/IM | not captured | standing | page 45 |
| Nerve agent exposure | peds | 0.05–0.1 mg/kg | IV/IM | not captured | standing | page 45 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 0.5–1 g | IV | not captured | standing | page 43 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | page 43 |
| Cardiac arrest | adult | 1 g | IV | not captured | standing | page 248 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 34 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 34 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | page 59 |
| Hypoglycemia | peds | 0.5 g/kg | IV | not captured | standing | page 59 |
| Other | adult | 25 g | IV | not captured | standing | page 59 |
| Other | peds | 0.5 g/kg | IV | not captured | standing | page 59 |
| Seizure | adult | 25 g | IV | not captured | standing | page 67 |
| Seizure | peds | 0.5 g/kg | IV | not captured | standing | page 67 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 2–10 mg | IV/IM | not captured | standing | page 45 |
| Seizure | peds | 0.2–0.5 mg/kg | IV/IM | not captured | standing | page 45 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | page 17 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 17 |
| Dystonic reaction | adult | 50 mg | IV | not captured | standing | page 43 |
| Dystonic reaction | peds | 1 mg/kg | IV | not captured | standing | page 43 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV | not captured | standing | page 252 |
| Bradycardia | peds | 5–20 mcg/kg | IV | not captured | standing | page 252 |
| Cardiogenic shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 252 |
| Cardiogenic shock | peds | 5–20 mcg/kg | IV | not captured | standing | page 252 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 16 |
| Anaphylaxis | adult | 0.3 mg | not captured | not captured | standing | page 16 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 16 |
| Anaphylaxis | peds | 0.15 mg | not captured | not captured | standing | page 16 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 95 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 95 |
| Hypotension / shock | adult | 1–2 mL | IV/IO | not captured | standing | page 14 |
| Hypotension / shock | peds | 0.1 mL/kg | IV/IO | not captured | standing | page 14 |
| Respiratory distress | adult | 0.3 mg | not captured | not captured | standing | page 63 |
| Respiratory distress | adult | 0.3 mg | IM | not captured | standing | page 64 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50–100 mcg | IV/IO | not captured | standing | page 163 |
| Other | adult | 50–100 mcg | IN | not captured | standing | page 163 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | page 163 |
| Other | peds | 1 mcg/kg | IN | not captured | standing | page 163 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO | not captured | standing | page 104 |
| Mild to moderate pain | adult | 1 mcg/kg | IN | not captured | standing | page 104 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO | not captured | standing | page 104 |
| Mild to moderate pain | peds | 1 mcg/kg | IN | not captured | standing | page 104 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 59 |
| Hypoglycemia | peds | 0.05 mg/kg | IM | not captured | standing | page 59 |
| Other | adult | 1 mg | IM | not captured | standing | page 59 |
| Other | peds | 0.05 mg/kg | IM | not captured | standing | page 59 |
| Seizure | adult | 1 mg | IM | not captured | standing | page 67 |
| Seizure | peds | 0.05 mg/kg | IM | not captured | standing | page 67 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV | not captured | standing | page 20 |
| Adrenal crisis | peds | 1–2 mg/kg | IV | not captured | standing | page 20 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5 mg | IV/IM | not captured | standing | page 154 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 258 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | page 258 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 10 mg/kg | PO | not captured | standing | page 153 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 153 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 500 mcg | NEB | not captured | standing | page 63 |
| Respiratory distress | peds | 250–500 mcg | NEB | not captured | standing | page 63 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 72 |
| Other | adult | 0.5 mg/kg | IN | not captured | standing | page 163 |
| Other | adult | 4 mg/kg | IM | not captured | standing | page 161 |
| Other | adult | 4 mg/kg | IN | not captured | standing | page 161 |
| Other | peds | 0.5 mg/kg | IN | not captured | standing | page 163 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 153 |
| Mild to moderate pain | adult | 0.5 mg/kg | IN | not captured | standing | page 153 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 153 |
| Mild to moderate pain | peds | 0.5 mg/kg | IN | not captured | standing | page 153 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | page 153 |
| Mild to moderate pain | peds | 1 mg/kg | IV/IM | not captured | standing | page 153 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 100 mg | IV/IO | not captured | standing | page 95 |
| Mild to moderate pain | adult | 20 mg | IO | not captured | standing | page 176 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 176 |
| Narrow-complex tachycardia | adult | 1 mg/kg | IV | not captured | standing | page 101 |
| Narrow-complex tachycardia | peds | 1 mg/kg | IV | not captured | standing | page 101 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 67 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 67 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 g | IV/IO | not captured | standing | page 265 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | page 67 |
| Respiratory distress | adult | 2 g | IV | not captured | standing | page 64 |
| Narrow-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 265 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 95 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV | not captured | standing | page 20 |
| Adrenal crisis | peds | 2 mg/kg | IV | not captured | standing | page 20 |
| Allergic reaction | adult | 125 mg | IV | not captured | standing | page 17 |
| Allergic reaction | peds | 2 mg/kg | IV | not captured | standing | page 17 |
| Respiratory distress | adult | 125 mg | IV | not captured | standing | page 64 |
| Respiratory distress | peds | 2 mg/kg | IV | not captured | standing | page 64 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 10 mg | IM | not captured | standing | page 72 |
| Hyperactive delirium | adult | 5 mg | IN | not captured | standing | page 72 |
| Nerve agent exposure | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 45 |
| Nerve agent exposure | adult | 0.1 mg/kg | IM | not captured | standing | page 45 |
| Nerve agent exposure | peds | 0.15 mg/kg | IM | not captured | standing | page 45 |
| Nerve agent exposure | peds | 0.15 mg/kg | IV/IO | not captured | standing | page 45 |
| Other | adult | 1–5 mg | IV/IO/IN | not captured | standing | page 163 |
| Other | adult | 1–5 mg | IV/IO/IN | not captured | standing | page 51 |
| Other | peds | 0.05 mg/kg | IV/IO/IN | not captured | standing | page 163 |
| Other | peds | 0.05 mg/kg | IV/IO/IN | not captured | standing | page 51 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 45 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 45 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | page 45 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 154 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 154 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IN | not captured | standing | page 239 |
| Opioid overdose | adult | 0.4 mg | IV/IO/IM | not captured | standing | page 240 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 239 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 240 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1-3 injectors | IM | not captured | standing | page 45 |
| Nerve agent exposure | peds | 1 injector | IM | not captured | standing | page 45 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 104 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 102 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 10 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | adult | 4 mg | IV/IO | not captured | standing | page 154 |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 154 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 154 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 50 mg | PO | not captured | standing | page 20 |
| Adrenal crisis | peds | 50 mg | PO | not captured | standing | page 20 |
| Allergic reaction | adult | 50 mg | PO | not captured | standing | page 17 |
| Allergic reaction | peds | 50 mg | PO | not captured | standing | page 17 |
| Respiratory distress | adult | 50 mg | PO | not captured | standing | page 64 |
| Respiratory distress | peds | 50 mg | PO | not captured | standing | page 64 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 100 mEq | IV | not captured | standing | page 34 |
| Crush injury | peds | 1 mEq/kg | IV | not captured | standing | page 34 |
| Hyperactive delirium | adult | 50 mEq | IV | not captured | standing | page 72 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 95 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 95 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 43 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 43 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV | not captured | standing | page 293 |
| Cyanide poisoning | peds | 1.65 mL/kg | IV | not captured | standing | page 293 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | not captured | not captured | standing | page 44 |
| Other | peds | 1–2 drop | not captured | not captured | standing | page 44 |
| Mild to moderate pain | adult | 1–2 drop | not captured | not captured | standing | page 44 |
| Mild to moderate pain | peds | 1–2 drop | not captured | not captured | standing | page 44 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 275 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 275 |